Cargando…
Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics
INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) is the fifth most common cause of cancer-related death in Europe with a 5-year survival rate of <5%. Chronic pancreatitis (CP) is a risk factor for PDAC development, but in the majority of cases malignancy is discovered too late for curative t...
Autores principales: | Lindahl, Anna, Heuchel, Rainer, Forshed, Jenny, Lehtiö, Janne, Löhr, Matthias, Nordström, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376388/ https://www.ncbi.nlm.nih.gov/pubmed/28413374 http://dx.doi.org/10.1007/s11306-017-1199-6 |
Ejemplares similares
-
Discrimination of conventional and organic white cabbage from a long-term field trial study using untargeted LC-MS-based metabolomics
por: Mie, Axel, et al.
Publicado: (2014) -
Cellular heterogeneity in pancreatic cancer: the different faces of gremlin action
por: Moustakas, Aristidis, et al.
Publicado: (2022) -
Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models
por: Gündel, Beate, et al.
Publicado: (2021) -
3D heterospecies spheroids of pancreatic stroma and cancer cells demonstrate key phenotypes of pancreatic ductal adenocarcinoma
por: Liu, Xinyuan, et al.
Publicado: (2021) -
Desmoplasia and Chemoresistance in Pancreatic Cancer
por: Schober, Marvin, et al.
Publicado: (2014)